INTECH Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

INTECH Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$823K	Sell	47,565 -10,137	-18%	-$139K	0.01%	1125
2026 Q1	$717K	Sell	57,702 -39,871	-41%	-$535K	0.01%	1168
2025 Q4	$1.23M	Buy	97,573 +1,159	+1%	+$13.3K	0.01%	1001
2025 Q3	$965K	Sell	96,414 -32,875	-25%	-$295K	0.01%	1184
2025 Q2	$1.05M	Buy	129,289 +17,534	+16%	+$132K	0.01%	1171
2025 Q1	$937K	Buy	111,755 +30,700	+38%	+$256K	0.01%	1233
2024 Q4	$642K	Buy	81,055 +44,208	+120%	+$371K	0.01%	1417
2024 Q3	$307K	Buy	+36,847	New	+$288K	﹤0.01%	1509

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

INTECH Investment Management's AMRX Position: Q2 2026 in Review

INTECH Investment Management reduced its Amneal Pharmaceuticals (AMRX) stake by 18% in Q2 2026, selling an estimated $139K and leaving 47,565 shares worth $823K. The position accounts for 0.01% of the portfolio, ranked #1125.

INTECH Investment Management first reported a position in AMRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.23M in Q4 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

INTECH Investment Management held 47,565 shares of Amneal Pharmaceuticals worth $823K as of Q2 2026.
INTECH Investment Management sold 10,137 Amneal Pharmaceuticals shares in Q2 2026, an estimated $139K.
Amneal Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1125 holding.
INTECH Investment Management first reported a position in Amneal Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Amneal Pharmaceuticals position peaked at $1.23M in Q4 2025.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.